Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 13c, Raises FY Revenue Guidance
Go back to Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 13c, Raises FY Revenue Guidance| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 243.84 +0.25 (0.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $243.59 | 52 Week High | $160.00 | |||
| Open | $246.59 | 52 Week Low | $95.80 | |||
| Day High | $247.31 | P/E | 45.32 | |||
| Day Low | $243.57 | EPS | $5.38 | |||
| Volume | 556,425 | |||||
